荣昌生物(SH 688331,收盘价:33.62元)2月27日晚间发布2024年度业绩快报,营业收入约17.15亿元,同比增加58.4%;归属于上市公司股东的净利润亏损约14.68亿元;基本每股收益亏损2.73元。(文章来源:每日经济新闻)
Source Link荣昌生物(SH 688331,收盘价:33.62元)2月27日晚间发布2024年度业绩快报,营业收入约17.15亿元,同比增加58.4%;归属于上市公司股东的净利润亏损约14.68亿元;基本每股收益亏损2.73元。(文章来源:每日经济新闻)
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.